Wednesday, November 18, 2009

Is running marathons damaging your health?

There is speculation from the scientific literature that marathon runners may be more susceptible to chronic inflammation and caradic events such as artrial fibrillation (abnormal heart rhythms). The research indicates that there is an association to artrial fibrillation and endurance running.

Furthermore, research demonstrates an interesting correlation between inflammation and artrial fibrillation in chronic endurance training and racing. The researchers believe that high levels of C-reactive protein(s) could be a risk factor for developing artrial fibrillation. C-reactive protein are produced in the liver or present in the blood in an inactive form that are turned on during times of inflammation such as running a marathon.

In addition, research published in the American Society for Clinical Research investigated elevations of an enzyme called myeloperoxidase (MPO) in runners that completed the Boston Marathon in 2005. The researchers looked at myeloperoxidase as a means to detect inflammation after endurance racing, which was statistically elevated after the race in 22 of the 24 runners. Interestingly enough, myeloperoxidase has been associated with coronary artery disease and atherosclerosis.

Systemic inflammation in respect to marathon running may contribute to a compromised cardiovascular system that may lead to chronic injuries and oxidative stress.

Seattle Budget Fitness Examiner Dave Guevara

Thursday, August 20, 2009

Major nutritional issues in the management of Parkinson's disease

Barichella M, Cereda E, Pezzoli G.
Parkinson Institute, Istituti Clinici di Perfezionamento, Milano, Italy.

As with other neurodegenerative diseases, neurologic and nutritional elements may interact affecting each other in Parkinson's disease (PD). However, the long-term effects of such interactions on prognosis and outcome have not been given much attention and are poorly addressed by current research.

Factors contributing to the clinical conditions of patients with PD are not only the basic features of PD, progression of disease, and the therapeutic approach but also fiber and nutrient intakes (in terms of both energy and protein content), fluid and micronutrient balance, and pharmaconutrient interactions (protein and levodopa). During the course of PD nutritional requirements frequently change. Accordingly, both body weight gain and loss may occur and, despite controversy, it seems that both changes in energy expenditure and food intake contribute. Nonmotor symptoms play a significant role and dysphagia may be responsible for the impairment of nutritional status and fluid balance. Constipation, gastroparesis, and gastro-oesophageal reflux significantly affect quality of life. Finally, any micronutrient deficiencies should be taken into account.

Nutritional assessments should be performed routinely. Optimization of pharmacologic treatment for both motor and nonmotor symptoms is essential, but nutritional interventions and counseling could and should also be planned with regard to nutritional balance designed to prevent weight loss or gain; optimization of levodopa pharmacokinetics and avoidance of interaction with proteins; improvement in gastrointestinal dysfunction (e.g., dysphagia and constipation); prevention and treatment of nutritional deficiencies (micronutrients or vitamins). A balanced Mediterranean-like dietary regimen should be recommended before the introduction of levodopa; afterward, patients with advanced disease may benefit considerably from protein redistribution and low-protein regimens.

Monday, June 22, 2009

Men's knowledge and beliefs about prostate cancer: education, race, and screening status.

OBJECTIVE: African American men die from prostate cancer at higher rates than do White men, a health disparity that may result from differences in knowledge and beliefs about prostate cancer and screening. Studies conflict on whether race or socioeconomic status affects knowledge of prostate cancer and screening. This study compared education, race, and screening status to determine how each factor shapes men's knowledge of prostate cancer and screening.

METHODS: In-depth interviews were conducted with 65 African American and White men, aged 40-64 years, with diverse educational backgrounds.

RESULTS: Education, not race or screening status, was associated with knowledge about the prostate gland, prostate cancer symptoms and screening tests, and fear of prostate cancer. The exception was knowledge about the prostate-specific antigen blood test, which was associated with education and screening status.

CONCLUSION: This study suggests that education may be associated with prostate cancer and screening knowledge. Interventions should focus on all men with low education to correct their misconceptions about prostate cancer and to engage them in shared decision-making about screening.

Winterich JA, Grzywacz JG, Quandt SA, Clark PE, Miller DP, Acuña J, Dignan MB, Arcury TA.
Department of Family and Community Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA